Trends in the pharmacological treatment of patients with schizophrenia over a 12 year observation period
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 77 (1) , 25-34
- https://doi.org/10.1016/j.schres.2005.01.015
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Prevalence, Trends, and Factors Associated With Antipsychotic Polypharmacy Among Medicaid-Eligible Schizophrenia Patients, 1998–2000The Journal of Clinical Psychiatry, 2004
- Dose Response and Dose Equivalence of AntipsychoticsJournal of Clinical Psychopharmacology, 2004
- Comparisons of psychotropic drug prescribing patterns in acute psychiatric wards across EuropeEuropean Journal of Clinical Pharmacology, 2004
- Inpatient Antipsychotic Drug Use in 1998, 1993, and 1989American Journal of Psychiatry, 2002
- Clozapine and Haloperidol in Moderately Refractory SchizophreniaArchives of General Psychiatry, 2001
- Changes in Use of Valproate and Other Mood Stabilizers for Patients With Schizophrenia From 1994 to 1998Psychiatric Services, 2000
- Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-responseBiological Psychiatry, 1999
- Translating Research Into Practice: The Schizophrenia Patient Outcomes Research Team (PORT) Treatment RecommendationsSchizophrenia Bulletin, 1998
- Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden.British Journal of Clinical Pharmacology, 1995
- Comment on the WHO Consensus StatementThe British Journal of Psychiatry, 1990